Posted February 02, 2018 05:03:14A week after the New York Rangers signed veteran defenseman Kevin Hayes to a two-year contract, it looks like he may have an answer for some of his symptoms.
The New York Times reported on Monday that Hayes, who missed the entire 2018-19 season with a concussion, is taking a medication called myxexedema, a form of corticosteroid medication that works by blocking a hormone in the brain that causes symptoms.
I’ve had a ton of stuff happen and not been able to get my head around that it was just a mental thing, Hayes said.
I was kind of hoping that this would help me get over that.
He said that he’ll take it for a couple of weeks, see how it goes, then he’ll make a decision on whether he’s going to play again.
Hayes was signed as part of the deal to fill out the roster of the Columbus Blue Jackets, who were eliminated from the playoffs by the Philadelphia Flyers in the first round.
The Flyers sent Hayes to Columbus for draft pick No. 51, which they used on goaltender Matt Murray and defenseman Jakub Voracek.
They also got the right to match any future contract Hayes signs, the paper reported.
The Rangers had an excellent season with Hayes in net, posting a league-best 23-4-4 record, good for second in the NHL behind only Anaheim.
The 34-year-old forward also posted career highs in goals (34), points (66), power-play goals (nine), game-winning goals (three) and game-ending goals (two).